Pediatric Endocrinology Diabetes and Metabolism

Abstract

2/2022 vol. 28
Review paper

Familial hypercholesterolemia – treatment update in children, systematic review

Sabina Ziółkowska 1
,
Noëlle Kijek 1
,
Iga Zendran 1
,
Ewa Szuster 1
,
Ewa Barg 2
  1. Graduate of Wroclaw Medical University, Poland
  2. Department of Basic Medical Sciences, Wroclaw Medical University, Poland
Pediatr Endocrinol Diabetes Metab 2022; 28 (2): 152–161
DOI: https://doi.org/10.5114/pedm.2022.116112
Online publish date: 2022/06/28
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Familial hypercholesterolaemia is one of the most common genetic diseases, and its first symptoms occur in childhood. Proper diagnosis and treatment prevent young patients from severe consequences in their future. The treatment of this dyslipidaemia is still evolving, and new promising agents are being discovered. In this review we summarize the old and new treatment methods of familial hypercholesterolaemia, giving an update estimated on the latest publications.

Keywords

hypercholesterolaemia, children, adolescents, hyperlipoproteinaemia, cholesterol

Share
without publication fees
Integrated with
integrated with publons
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications